Sweet Geezer ...: BMY: Bristol-Myers Squibb outlines $46B–$47.5B 2026 revenue target as growth portfolio nears 60% of sales, driven by new product launches and pipeline catalysts

Bristol-Myers Squibb outlines $46B–$47.5B 2026 revenue target as growth portfolio nears 60% of sales, driven by new product launches and pipeline catalysts

06:05 PM | Bristol-Myers Squibb Company (BMY) | By: SA Transcript Insights Editor, SA News Editor

Unlimited access to news. Read now >>

You may also like:

FEATURED: Try Seeking Alpha Premium—just $4.95 for your first month** Claim Offer »

Manage Alerts | Trending News | Free Newsletters

Download the Seeking Alpha App!

Like our Breaking News? Try our other newsletters as well.

**Introductory offer for new subscribers only. After your introductory trial, $299 is charged automatically for an annual subscription unless you cancel during your trial. Auto-renews annually. Plus sales tax/VAT where applicable.

This email was sent to you because you signed up to receive this Breaking News Alert. If you do not want to receive these real-time alerts, click here to unsubscribe.

Past performance is no guarantee of future results. Any content and tools on the platform are offered for information purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Sent by Seeking Alpha, 244 5th Ave, Suite 2705, New York, NY 10001

Pages

Thursday, February 5, 2026

BMY: Bristol-Myers Squibb outlines $46B–$47.5B 2026 revenue target as growth portfolio nears 60% of sales, driven by new product launches and pipeline catalysts

Total Pageviews

We Are Participants in ... Are You?

Mz Geezer